<![CDATA[This study aims to analyze Net Profit Margin (NPM) and Price Earning Ratio (PER) as a measure of Financial Distress in pharmaceutical sub-sector consumer goods industry sector companies listed on the Indonesia Stock Exchange for the period 2018-2022. The research method used is descriptive quantitative. The research population is all pharmaceutical sub-sector companies listed on the IDX, with a sample of 5 companies selected using purposive sampling technique. The data used is secondary data in the form of annual financial reports. The results showed that NPM proved effective in measuring the potential for Financial Distress, with companies that have stable or increasing NPM showing a low risk of Financial Distress. PER provides insight into the market's valuation of the company, but its interpretation in the context of Financial Distress must consider other factors. The combined analysis of NPM and PER indicates that KLBF and TSPC have the lowest risk of Financial Distress, while INAF shows the clearest signs of potential Financial Distress. This study concludes that NPM and PER can be used as an initial measurement tool to detect potential Financial Distress, but a more comprehensive analysis is needed for a more accurate assessment.]]>
Copyrights © 2024
